<?xml version="1.0" encoding="UTF-8"?>
<p id="para20">Organisations including 
 <ext-link ext-link-type="uri" xlink:href="https://www.unaids.org/en/covid19" id="interrefs10" xmlns:xlink="http://www.w3.org/1999/xlink">UNAIDS</ext-link>, UNICEF, and the 
 <ext-link ext-link-type="uri" xlink:href="https://www.iasociety.org/covid-19-hiv" id="interrefs20" xmlns:xlink="http://www.w3.org/1999/xlink">International AIDS Society</ext-link> have begun to issue guidance and advice on how to deal with COVID-19 in high HIV burden settings. The 
 <ext-link ext-link-type="uri" xlink:href="https://www.theglobalfund.org/en/news/2020-03-04-global-fund-issues-new-guidance-in-response-to-covid-19/" id="interrefs30" xmlns:xlink="http://www.w3.org/1999/xlink">Global Fund</ext-link> to Fight HIV, Tuberculosis and Malaria has also urged recipients to divert surplus funds to prepare and respond to COVID-19. We do know, however, that the response to SARS-CoV-2 is compromising HIV programmes. As global travel and transport are disrupted, drug supply chains are jeopardised. In a Comment, Weiming Tang and colleagues highlight the contributions of non-governmental organisations stepping in to ensure consistency in HIV care during the SARS-CoV-2 pandemic.
</p>
